Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 88, No. 4, 2010
Issue release date: July 2010
Section title: Clinical Study
Free Access
Stereotact Funct Neurosurg 2010;88:224–233
(DOI:10.1159/000314357)

Patient-Specific Model-Based Investigation of Speech Intelligibility and Movement during Deep Brain Stimulation

Åström M.a · Tripoliti E.c · Hariz M.I.b, c · Zrinzo L.U.c · Martinez-Torres I.c · Limousin P.c · Wårdell K.a
aDepartment of Biomedical Engineering, Linköping University, Linköping, and bDepartment of Neurosurgery, University Hospital, Umeå, Sweden; cInstitute of Neurology, University College, London, UK
email Corresponding Author

Mattias Åström, MSc

Department of Biomedical Engineering

Linköping University

SE–58185 Linköping (Sweden)

Tel. +46 736 290 978, E-Mail matas@imt.liu.se


References

  1. Limousin P, Krack P, Pollak P, Benazzouz A, Ardouin C, Hoffmann D, Benabid AL: Electrical stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 1998;339:1105–1111.
  2. Krack P, Batir A, Van Blercom N, Chabardes S, Fraix V, Ardouin C, Koudsie A, Limousin PD, Benazzouz A, LeBas JF, Benabid AL, Pollak P: Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N Engl J Med 2003;349:1925–1934.
  3. Moro E, Scerrati M, Romito LM, Roselli R, Tonali P, Albanese A: Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson’s disease. Neurology 1999;53:85–90.
  4. Schulz GM, Grant MK: Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson’s disease: a review of the literature. J Commun Disord 2000;33:59–88.
  5. Ramig LO, Dromey C: Aerodynamic mechanisms underlying treatment-related changes in vocal intensity in patients with Parkinson disease. J Speech Hear Res 1996;39:798–807.
  6. Ho AK, Iansek R, Marigliani C, Bradshaw JL, Gates S: Speech impairment in a large sample of patients with Parkinson’s disease. Behav Neurol 1998;11:131–137.
  7. Logemann JA, Fisher HB, Boshes B, Blonsky ER: Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients. J Speech Hear Disord 1978;43:47–57.
  8. Darley FL, Aronson AE, Brown JR: Clusters of deviant speech dimensions in the dysarthrias. J Speech Hear Res 1969;12:462–496.
  9. Darley FL, Aronson AE, Brown JR: Differential diagnostic patterns of dysarthria. J Speech Hear Res 1969;12:246–269.
  10. Rousseaux M, Krystkowiak P, Kozlowski O, Ozsancak C, Blond S, Destee A: Effects of subthalamic nucleus stimulation on parkinsonian dysarthria and speech intelligibility. J Neurol 2004;251:327–334.
  11. Romito LM, Scerrati M, Contarino MF, Iacoangeli M, Bentivoglio AR, Albanese A: Bilateral high frequency subthalamic stimulation in Parkinson’s disease: long-term neurological follow-up. J Neurosurg Sci 2003;47:119–128.
  12. Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N: Bilateral deep brain stimulation in Parkinson’s disease: a multicentre study with 4 years follow-up. Brain 2005;128:2240–2249.
  13. Törnqvist AL, Schalen L, Rehncrona S: Effects of different electrical parameter settings on the intelligibility of speech in patients with Parkinson’s disease treated with subthalamic deep brain stimulation. Mov Disord 2005;20:416–423.
  14. Guehl D, Cuny E, Benazzouz A, Rougier A, Tison F, Machado S, Grabot D, Gross C, Bioulac B, Burbaud P: Side-effects of subthalamic stimulation in Parkinson’s disease: clinical evolution and predictive factors. Eur J Neurol 2006;13:963–971.
  15. Klostermann F, Ehlen F, Vesper J, Nubel K, Gross M, Marzinzik F, Curio G, Sappok T: Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2008;79:522–529.
  16. Piboolnurak P, Lang AE, Lozano AM, Miyasaki JM, Saint-Cyr JA, Poon YY, Hutchison WD, Dostrovsky JO, Moro E: Levodopa response in long-term bilateral subthalamic stimulation for Parkinson’s disease. Mov Disord 2007;22:990–997.
  17. Farrell A, Theodoros D, Ward E, Hall B, Silburn P: Effects of neurosurgical management of Parkinson’s disease on speech characteristics and oromotor function. J Speech Lang Hear Res 2005;48:5–20.
  18. D’Alatri L, Paludetti G, Contarino MF, Galla S, Marchese MR, Bentivoglio AR: Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment. J Voice 2008;22:365–372.
  19. Gentil M, Pinto S, Pollak P, Benabid AL: Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian dysarthria. Brain Lang 2003;85:190–196.
  20. Pinto S, Gentil M, Fraix V, Benabid AL, Pollak P: Bilateral subthalamic stimulation effects on oral force control in Parkinson’s disease. J Neurol 2003;250:179–187.
  21. Dromey C, Kumar R, Lang AE, Lozano AM: An investigation of the effects of subthalamic nucleus stimulation on acoustic measures of voice. Mov Disord 2000;15:1132–1138.
  22. Gentil M, Garcia-Ruiz P, Pollak P, Benabid AL: Effect of stimulation of the subthalamic nucleus on oral control of patients with parkinsonism. J Neurol Neurosurg Psychiatry 1999;67:329–333.
  23. Tripoliti E, Zrinzo L, Martinez-Torres I, Tisch S, Frost E, Borrell E, Hariz MI, Limousin P: Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation. Mov Disord 2008;23:2377–2383.
  24. Åstrom M, Zrinzo LU, Tisch S, Tripoliti E, Hariz MI, Wårdell K: Method for patient-specific finite element modeling and simulation of deep brain stimulation. Med Biol Eng Comput 2009;47:21–28.
  25. Hariz MI, Krack P, Melvill R, Jorgensen JV, Hamel W, Hirabayashi H, Lenders M, Wesslen N, Tengvar M, Yousry TA: A quick and universal method for stereotactic visualization of the subthalamic nucleus before and after implantation of deep brain stimulation electrodes. Stereotact Funct Neurosurg 2003;80:96–101.
  26. Yorkston KM, Beukelman DR: Communication efficiency of dysarthric speakers as measured by sentence intelligibility and speaking rate. J Speech Hear Disord 1981;46:296–301.
  27. Andreuccetti D, Fossi R, Petrucci C: Dielectric properties of body tissue. Italian National Research Council, Institute for Applied Physics, Florence, Italy. 2005. http://niremf.ifac.cnr.it/tissprop/.
  28. Åström M, Zrinzo LU, Tisch S, Tripoliti E, Hariz MI, Wårdell K: Method for patient-specific finite element modeling and simulation of deep brain stimulation. Med Biol Eng Comput 2009;47:21–28.
  29. Butson CR, McIntyre CC: Differences among implanted pulse generator waveforms cause variations in the neural response to deep brain stimulation. Clin Neurophysiol 2007;118:1889–1894.
  30. Cheng DK: Field and Wave Electromagnetics. Reading, Addison-Wesley Publishing Company Inc, 1989.
  31. Gallay MN, Jeanmonod D, Liu J, Morel A: Human pallidothalamic and cerebellothalamic tracts: anatomical basis for functional stereotactic neurosurgery. Brain Struct Funct 2008;212:443–463.
  32. Morel A: Stereotactic Atlas of the Human Thalamus and Basal Ganglia. New York, Informa Healthcare, 2007.
  33. Krack P, Fraix V, Mendes A, Benabid AL, Pollak P: Postoperative management of subthalamic nucleus stimulation for Parkinson’s disease. Mov Disord 2002;17(suppl 3):S188–S197.
  34. Pinto S, Gentil M, Krack P, Sauleau P, Fraix V, Benabid AL, Pollak P: Changes induced by levodopa and subthalamic nucleus stimulation on parkinsonian speech. Mov Disord 2005;20:1507–1515.
  35. Deuschl G, Herzog J, Kleiner-Fisman G, Kubu C, Lozano AM, Lyons KE, Rodriguez-Oroz MC, Tamma F, Troster AI, Vitek JL, Volkmann J, Voon V: Deep brain stimulation: postoperative issues. Mov Disord 2006;21(suppl 14):S219–S237.
  36. Tripoliti E, Limousin P, Tisch S, Borrell E, Hariz M: Speech in Parkinson’s disease following subthalamic nucleus deep brain stimulation: preliminary results. J Med Speech Lang Pathol 2006;14:309–315.
    External Resources
  37. Plaha P, Ben-Shlomo Y, Patel NK, Gill SS: Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 2006;129:1732–1747.
  38. Velasco F, Jimenez F, Perez ML, Carrillo-Ruiz JD, Velasco AL, Ceballos J, Velasco M: Electrical stimulation of the prelemniscal radiation in the treatment of Parkinson’s disease: an old target revised with new techniques. Neurosurgery 2001;49:293–306.
  39. Santens P, De Letter M, Van Borsel J, De Reuck J, Caemaert J: Lateralized effects of subthalamic nucleus stimulation on different aspects of speech in Parkinson’s disease. Brain Lang 2003;87:253–258.
  40. Wang E, Verhagen Metman L, Bakay R, Arzbaecher J, Bernard B: The effect of unilateral electrostimulation of the subthalamic nucleus on respiratory/phonatory subsystems of speech production in Parkinson’s disease – A preliminary report. Clin Linguist Phon 2003;17:283–289.
  41. Wang EQ, Metman LV, Bakay RA, Arzbaecher J, Bernard B, Corcos DM: Hemisphere-specific effects of subthalamic nucleus deep brain stimulation on speaking rate and articulatory accuracy of syllable repetitions in Parkinson’s disease. J Med Speech Lang Pathol 2006;14:323–334.